Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview

被引:10
作者
Peters, Frank T. [1 ,2 ]
Wissenbach, Daniela [1 ]
机构
[1] Jena Univ Hosp, Friedrich Schiller Univ, Inst Forens Med, Jena, Germany
[2] Jena Univ Hosp, Friedrich Schiller Univ, Inst Forens Med, Klinikum 1, D-07747 Jena, Germany
关键词
Clinical toxicology; mass spectrometry; liquid chromatography; gas chromatography; systematic toxicological analysis; drugs of abuse testing; high-resolution mass spectrometry; PSYCHOACTIVE SUBSTANCES; FORENSIC TOXICOLOGY; SYNTHETIC CANNABINOIDS; ETHYLENE-GLYCOL; LC-MS; HUMAN SERUM; URINE; DRUGS; RELEVANT; METABOLITES;
D O I
10.1080/17425255.2023.2252324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IntroductionHyphenated mass spectrometry (MS) has evolved into a very powerful analytical technique of high sensitivity and specificity. It is used to analyze a very wide spectrum of analytes in classical and alternative matrices. The presented paper will provide an overview of the current state-of-the-art of hyphenated MS applications in clinical toxicology primarily based on review articles indexed in PubMed (1990 to April 2023).Areas coveredA general overview of matrices, sample preparation, analytical systems, detection modes, and validation and quality control is given. Moreover, selected applications are discussed.Expert opinionA more widespread use of hyphenated MS techniques, especially in systematic toxicological analysis and drugs of abuse testing, would help overcome limitations of immunoassay-based screening strategies. This is currently hampered by high instrument cost, qualification requirements for personnel, and less favorable turnaround times, which could be overcome by more user-friendly, ideally fully automated MS instruments. This would help making hyphenated MS-based analysis available in more laboratories and expanding analysis to a large number of organic drugs, poisons, and/or metabolites. Even the most recent novel psychoactive substances (NPS) could be presumptively identified by high-resolution MS methods, their likely presence be communicated to treating physicians, and be confirmed later on.
引用
收藏
页码:487 / 500
页数:14
相关论文
共 112 条
[1]  
Allen Darren R, 2019, Clin Biochem Rev, V40, P135, DOI [10.33176/aacb-19-00023, 10.33176/AACB-19-00023]
[2]   Alcohol Biomarkers in Clinical and Forensic Contexts [J].
Andresen-Streichert, Hilke ;
Muller, Alexander ;
Glahn, Alexander ;
Skopp, Gisela ;
Sterneck, Martina .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (18) :309-+
[3]  
[Anonymous], 2022, New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (June 2022)
[4]   Reference materials for new psychoactive substances [J].
Archer, Roland P. ;
Treble, Ric ;
Williams, Keith .
DRUG TESTING AND ANALYSIS, 2011, 3 (7-8) :505-514
[5]   Analysis of α- and β-amanitin in Human Plasma at Subnanogram per Milliliter Levels by Reversed Phase Ultra-High Performance Liquid Chromatography Coupled to Orbitrap Mass Spectrometry [J].
Bambauer, Thomas P. ;
Wagmann, Lea ;
Weber, Armin A. ;
Meyer, Markus R. .
TOXINS, 2020, 12 (11)
[6]   Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions [J].
Bambauer, Thomas P. ;
Wagmann, Lea ;
Weber, Armin A. ;
Meyer, Markus R. .
DRUG TESTING AND ANALYSIS, 2021, 13 (09) :1603-1613
[7]   Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS [J].
Bambauer, Thomas P. ;
Wagmann, Lea ;
Maurer, Hans H. ;
Weber, Armin A. ;
Meyer, Markus R. .
TALANTA, 2020, 213
[8]  
Barile FA., 2010, INTRO BASIC TOXICO 1
[9]   Ambient ionization mass spectrometry applied to new psychoactive substance analysis [J].
Boronat Ena, Maria del Mar ;
Cowan, David A. ;
Abbate, Vincenzo .
MASS SPECTROMETRY REVIEWS, 2023, 42 (01) :3-34
[10]   Oral Fluid Testing for Drugs of Abuse [J].
Bosker, Wendy M. ;
Huestis, Marilyn A. .
CLINICAL CHEMISTRY, 2009, 55 (11) :1910-1931